LONDON - Oncimmune Holdings PLC (AIM: ONC.L), a company specializing in autoantibody profiling for the pharmaceutical and biotechnology sectors, has announced the scheduling of a General Meeting (GM) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback